CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 5th Interim Announcement

DGAP Post-admission Duties announcement: CompuGroup Medical SE & Co. KGaA / Share Buy-Back CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 5th Interim Announcement 06.04.2021 / 17:48 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 5th Interim Announcement In the period from March 29, 2021 until and including April 1, 2021, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 122,018 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on February 25, 2021 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on February 26, 2021 and which has been increased and extended as per announcement on March 25, 2021. The aggregate number of shares bought back each day during the period from March 29, 2021 until and including April 1, 2021 as well as the daily volume-weighted average prices for such buy-backs are as follows: Date Aggregate volume (number of no-par value shares) Volume-weighted average price (in EUR, excluding ancillary costs and charges) March 29, 2021 31,413 72.9169 March 30, 2021 31,375 72.9430 March 31, 2021 29,065 72.1946 April 1, 2021 30,165 72.6032 Total: 122,018 72.6740   The aggregate number of shares bought back within the share buy-back program in the period from February 26, 2021 until and including April 1, 2021 amounts to 650,832 shares. Detailed information about the transactions are published on the company's website under www.cgm.com/sbb. The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading). Koblenz, April 6, 2021 CompuGroup Medical SE & Co. KGaA The general partner 06.04.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	CompuGroup Medical SE & Co. KGaA
	Maria Trost 21
	56070 Koblenz
	Germany
Internet:	www.cgm.com

End of News	DGAP News Service

1181501  06.04.2021